Bristol-Myers Squibb Co (CHIX:BRMD) Construction In Progress : €1,532 Mil (As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Bristol-Myers Squibb Co Construction In Progress?

Bristol-Myers Squibb Co's quarterly construction in progress increased from Sep. 2024 (€1,232 Mil) to Dec. 2024 (€1,456 Mil) and increased from Dec. 2024 (€1,456 Mil) to Mar. 2025 (€1,532 Mil).

Bristol-Myers Squibb Co's annual construction in progress declined from Dec. 2022 (€994 Mil) to Dec. 2023 (€986 Mil) but then increased from Dec. 2023 (€986 Mil) to Dec. 2024 (€1,456 Mil).

Bristol-Myers Squibb Co Construction In Progress Historical Data

The historical data trend for Bristol-Myers Squibb Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Construction In Progress Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Construction In Progress

Get a 7-Day Free Trial

400.31

676.14

994.03

985.78

1,456.38

Bristol-Myers Squibb Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Construction In Progress	Get a 7-Day Free Trial															1,115.96	1,165.90	1,231.67	1,456.38	1,531.80

Bristol-Myers Squibb Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Bristol-Myers Squibb Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (CHIX:BRMd) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy 0R1F:UK BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina

Address

Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Bristol-Myers Squibb Co Headlines

No Headlines